Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Neil Desai Sells 4,982 Shares

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) Chairman Neil Desai sold 4,982 shares of the stock in a transaction on Thursday, June 1st. The stock was sold at an average price of $7.92, for a total value of $39,457.44. Following the transaction, the chairman now owns 1,826,561 shares of the company’s stock, valued at $14,466,363.12. […]

Related Keywords

Canada ,Neil Desai ,Los Angeles ,Aadi Bioscience ,Nasdaq ,Barclays Plc ,Aadi Bioscience Inc ,Securities Exchange Commission ,Group Plc ,Aadi Bioscience Company Profile ,Royal Bank ,Get Rating ,Chairman Neil Desai ,Exchange Commission ,General Group Plc ,Aadi Bioscience Daily ,Nasdaq Aadi ,Maadi ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,